2018 Post Operative Nausea And Vomiting Drug Development- Pipeline Analysis Report
Postoperative nausea and vomiting (PONV) is observed in around one-tenth of patients undergoing anesthesia administration. It is a complex disease and can cause wound dehiscence, electrolyte imbalance, dehydration among others.
Around 10 companies and universities are focusing on developing treatment options for Post Operative Nausea and Vomiting.
To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Post Operative Nausea and Vomiting pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.
Current status, developmental phase, participating companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Post Operative Nausea and Vomiting pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.
In addition to complete details of each product, the report provides key trends in Post Operative Nausea and Vomiting pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
Around 10 companies and universities are focusing on developing treatment options for Post Operative Nausea and Vomiting.
To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Post Operative Nausea and Vomiting pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.
Current status, developmental phase, participating companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Post Operative Nausea and Vomiting pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.
In addition to complete details of each product, the report provides key trends in Post Operative Nausea and Vomiting pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
1 TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2 POST OPERATIVE NAUSEA AND VOMITING PIPELINE ANALYSIS
2.1 Disease and Pipeline Overview
2.2 Post Operative Nausea And Vomiting Pipeline Snapshot
2.3 Post Operative Nausea And Vomiting Pipeline by Phase
2.4 Post Operative Nausea And Vomiting Pipeline by Company
2.5 Post Operative Nausea And Vomiting Pipeline by Mechanism of Action
3 POST OPERATIVE NAUSEA AND VOMITING- COMPANY WISE PIPELINE ANALYSIS
Acacia Pharma
Amherst Pharmaceuticals LLC
Braeburn Pharmaceuticals
Camurus AB
Kwang Dong Pharmaceutical Co Ltd
Suda Ltd
4 POST OPERATIVE NAUSEA AND VOMITING R&D PIPELINE SNAPSHOTS
Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details
5 RECENT DEVELOPMENTS IN POST OPERATIVE NAUSEA AND VOMITING PIPELINE
6 APPENDIX
6.1 About VPA Research
6.2 Sources and Research Methodology
1.1 List of Figures
1.2 List of Tables
2 POST OPERATIVE NAUSEA AND VOMITING PIPELINE ANALYSIS
2.1 Disease and Pipeline Overview
2.2 Post Operative Nausea And Vomiting Pipeline Snapshot
2.3 Post Operative Nausea And Vomiting Pipeline by Phase
2.4 Post Operative Nausea And Vomiting Pipeline by Company
2.5 Post Operative Nausea And Vomiting Pipeline by Mechanism of Action
3 POST OPERATIVE NAUSEA AND VOMITING- COMPANY WISE PIPELINE ANALYSIS
Acacia Pharma
Amherst Pharmaceuticals LLC
Braeburn Pharmaceuticals
Camurus AB
Kwang Dong Pharmaceutical Co Ltd
Suda Ltd
4 POST OPERATIVE NAUSEA AND VOMITING R&D PIPELINE SNAPSHOTS
Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details
5 RECENT DEVELOPMENTS IN POST OPERATIVE NAUSEA AND VOMITING PIPELINE
6 APPENDIX
6.1 About VPA Research
6.2 Sources and Research Methodology
LIST OF FIGURES
Figure 1: Post Operative Nausea And Vomiting Pipeline by Phase, H1- 2018
Figure 2: Post Operative Nausea And Vomiting Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Post Operative Nausea And Vomiting Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018
Figure 1: Post Operative Nausea And Vomiting Pipeline by Phase, H1- 2018
Figure 2: Post Operative Nausea And Vomiting Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Post Operative Nausea And Vomiting Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018
LIST OF TABLES
Table 1: Post Operative Nausea And Vomiting Pipeline by Phase, H1- 2018
Table 2: Post Operative Nausea And Vomiting Pipeline by Companies, H1- 2018
Table 3: Post Operative Nausea And Vomiting Pipeline by Mechanism of Action, H1- 2018
Table 4: Acacia Pharma Post Operative Nausea And Vomiting Pipeline, May 2018
Table 5: Amherst Pharmaceuticals LLC Post Operative Nausea And Vomiting Pipeline, May 2018
Table 6: Braeburn Pharmaceuticals Post Operative Nausea And Vomiting Pipeline, May 2018
Table 7: Camurus AB Post Operative Nausea And Vomiting Pipeline, May 2018
Table 8: Kwang Dong Pharmaceutical Co Ltd Post Operative Nausea And Vomiting Pipeline, May 2018
Table 9: Suda Ltd Post Operative Nausea And Vomiting Pipeline, May 2018
Table 1: Post Operative Nausea And Vomiting Pipeline by Phase, H1- 2018
Table 2: Post Operative Nausea And Vomiting Pipeline by Companies, H1- 2018
Table 3: Post Operative Nausea And Vomiting Pipeline by Mechanism of Action, H1- 2018
Table 4: Acacia Pharma Post Operative Nausea And Vomiting Pipeline, May 2018
Table 5: Amherst Pharmaceuticals LLC Post Operative Nausea And Vomiting Pipeline, May 2018
Table 6: Braeburn Pharmaceuticals Post Operative Nausea And Vomiting Pipeline, May 2018
Table 7: Camurus AB Post Operative Nausea And Vomiting Pipeline, May 2018
Table 8: Kwang Dong Pharmaceutical Co Ltd Post Operative Nausea And Vomiting Pipeline, May 2018
Table 9: Suda Ltd Post Operative Nausea And Vomiting Pipeline, May 2018
